# SHARE(D) Stage II: Alzheimer's Risk Disclosure Protocol Piloting

> **NCT04309500** · NA · COMPLETED · sponsor: **University of Michigan** · enrollment: 20 (actual)

## Conditions studied

- Mild Cognitive Impairment
- Healthy Aging

## Interventions

- **BEHAVIORAL:** Personalized DAT Risk Disclosure Protocol

## Key facts

- **NCT ID:** NCT04309500
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-20
- **Primary completion:** 2022-01-31
- **Final completion:** 2022-01-31
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2023-02-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04309500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04309500, "SHARE(D) Stage II: Alzheimer's Risk Disclosure Protocol Piloting". Retrieved via AI Analytics 2026-08-24 from https://api.ai-analytics.org/clinical/NCT04309500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*